Sirona Biochem (CVE:SBM) Reaches New 12-Month Low at $0.04

Shares of Sirona Biochem Corp. (CVE:SBMGet Free Report) hit a new 52-week low on Friday . The stock traded as low as C$0.04 and last traded at C$0.05, with a volume of 75975 shares. The stock had previously closed at C$0.05.

Sirona Biochem Stock Performance

The company has a market capitalization of C$11.48 million, a price-to-earnings ratio of -6.00 and a beta of -0.44. The firm has a 50-day simple moving average of C$0.06 and a two-hundred day simple moving average of C$0.08. The company has a current ratio of 0.39, a quick ratio of 2.41 and a debt-to-equity ratio of 219.21.

About Sirona Biochem

(Get Free Report)

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.

Read More

Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.